theMednetRegister
  • Community
    • Overview
    • Experts
    • Editors
    • Fellows
    • Code of conduct
    • AI Guidelines for Physicians
  • Company
    • About Us
    • FAQs
    • Privacy Policy
    • Terms of Use
    • Careers
    • Programs
  • News
    • News Releases
    • Press Coverage
    • Publications
    • Blog
  • Contact Us
  • Sign in

Case Western   

Questions discussed in this category


For patients with well differentiated NET whose carcinoid symptoms are controlled on SSAs but have persistently elevated 5HIAA, would you consider adding telotristat for prevention of carcinoid heart disease?
How aggressive should we be in bringing elevated plasma/urine 5HIAA to normal levels in patients whose symptoms are controlled? Before we have the res...
1 Answer available
10755


Papers discussed in this category


Circulation, 1995-08-15
Carcinoid heart disease. Correlation of high serotonin levels with valvular abnormalities detected by cardiac catheterization and echocardiography.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2017-01
Telotristat Ethyl, a Tryptophan Hydroxylase Inhibitor for the Treatment of Carcinoid Syndrome.

Endocrine-related cancer, 2018-03
Telotristat ethyl in carcinoid syndrome: safety and efficacy in the TELECAST phase 3 trial.

Related Topics

  • Medical Oncology
  • Neuroendocrine Tumors
  • NCI-CCC Tumor Board Question
  • NCI-CCC Neuroendocrine Tumor Board

Copyright © 2025 theMednet
All Rights Reserved.